Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000950170-25-042725

Chief Executive Officer sold 26,172 shares at an average $8.77 ($229,624)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Tak Paul Peter Chief Executive Officer 2025-03-18 Sale 10b5-1 −25,772 $8.77 $226,023 226,140 D: show line 1 in the form
Tak Paul Peter Chief Executive Officer 2025-03-19 Sale 10b5-1 −400 $9.00 $3,601 225,740 D: show line 2 in the form
Open-market sales · 26,172 sh · avg $8.77 · $229,624
Loading xslF345X05/ownership.xml…